On 20 November 2017, European Union (EU) Member States decided to relocate the European Medicines Agency (EMA) to Amsterdam, the Netherlands, as a result of the United Kingdom's (UK) withdrawal from the EU. The Agency immediately began working with the Dutch authorities to prepare for the move and take up its operations in Amsterdam on 30 March 2019 at the latest. EMA and the Netherlands have agreed a?joint governance structure?to steer and oversee the relocation project, with plans to progress activities within individual work streams dealing with EMA's temporary premises, its permanent premises, staff relocation, financial and legal aspects, removal and logistics and external communication.